HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The intracarotid amobarbital procedure as a predictor of memory failure following unilateral temporal lobectomy.

Abstract
We investigated the efficacy of the intracarotid amobarbital procedure to accurately predict post-temporal lobectomy anterograde amnesia. We presented items at 2 separate times during amobarbital assessment; both early and late item recall were decreased during the injection contralateral to seizure onset indicating sensitivity to bilateral temporal lobe dysfunction. Ten patients for whom follow-up neuropsychological assessment was available failed either the early or late item recognition portions of their amobarbital evaluation ipsilateral to seizure onset, but had hippocampus included in the temporal lobectomy by virtue of satisfactory performance on other tests of hippocampal function. None of these 10 patients displayed postoperative anterograde amnesia, although there was a reduction in material-specific memory in some patients. These results indicate that relying solely on amobarbital memory testing to assess the functional ability of the contralateral temporal lobe to sustain global memory prior to temporal lobectomy may needlessly exclude patients from a viable therapeutic option.
AuthorsD W Loring, G P Lee, K J Meador, H F Flanigin, J R Smith, R E Figueroa, R C Martin
JournalNeurology (Neurology) Vol. 40 Issue 4 Pg. 605-10 (Apr 1990) ISSN: 0028-3878 [Print] United States
PMID2320233 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Amobarbital
Topics
  • Amnesia (diagnosis, etiology)
  • Amobarbital (administration & dosage)
  • Carotid Arteries
  • Epilepsy (surgery)
  • Follow-Up Studies
  • Hippocampus (surgery)
  • Humans
  • Injections
  • Memory (drug effects)
  • Temporal Lobe (surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: